Serum Institute of India
-
Interview: Low-cost malaria vaccine could help eradicate disease by 2040, says expert
Adrian Hill, The Conversation
-
Covid-19 booster doses have little demand as citizens are fed up of pandemic: Serum Institute CEO
Scroll Staff
-
Serum Institute duped of Rs 1.01 crore by fraudster posing as Adar Poonawalla
Scroll Staff
-
Serum Institute halts Covid vaccine production due to millions of unused doses
Scroll Staff
-
Covid-19 vaccines are not mandatory, Centre tells Supreme Court
Scroll Staff
-
Coronavirus: Serum Institute’s Covovax vaccine gets WHO emergency use approval
Scroll Staff
-
Covishield shot for Omicron variant possible if needed, says Serum Institute CEO
Scroll Staff
-
Coronavirus: Covishield was effective during surge of Delta cases in India, says Lancet study
Scroll Staff
-
Covid-19: Covovax trials on children to begin in Pune hospital from Monday
Scroll Staff
-
Coronavirus: Serum Institute’s chief expresses reservation on mixing of vaccine doses
Scroll Staff
-
Top 10 updates: Indians must assimilate Covid-appropriate behaviour as the new normal, says Centre
Scroll Staff
-
Coronavirus: Not received request for approving Covishield for ‘vaccination passport’, says EU
Scroll Staff
-
Covishield beneficiaries facing travel problem, matter taken up at ‘highest levels’, says SII
Scroll Staff
-
Serum Institute gets permission to manufacture Sputnik V vaccine, say reports
Scroll Staff
-
Covid-19: Serum Institute chief thanks US after it lifts curbs on raw material export for vaccines
Scroll Staff
-
Serum Institute seeks protection from legal liability, says ‘rules should be same for everyone’
Scroll Staff
-
Even if WTO waives IP on vaccines, India will face challenge translating this into mass production
Yogesh Pai Prashant Reddy T
-
Coronavirus: Will supply 9-10 crore Covishield doses in June, Serum Institute tells Centre
Scroll Staff
-
Centre ignored stock availability, WHO guidelines for vaccination, says Serum Institute official
Scroll Staff
-
Covid-19: Haven’t exported vaccines at the cost of people in India, says Serum Institute
Scroll Staff